Skip to main content
    M

    Milestone Scientific (MLSS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $0.29
    -0.01 (-4.56%)

    Market Cap: $27.82M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Milestone Scientific (MLSS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 13, 2026. Financial statements from company filings, amounts in US dollars.

    Milestone Scientific reported revenue of $8.97M for the fiscal year ended Dec 31, 2025, up 4.0% from the year before. That year, net income was -$5.72M with a net margin of -63.8%, operating cash flow was -$2.92M and free cash flow was -$2.93M. The quarter ended Sep 30, 2026 had revenue of $2.22M and net income of -$747.54K.

    Revenue and Margins

    The operating margin was -63.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $10.48M, a compound annual decline of 1.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$8.97M+4.0%71.4%-63.5%-63.8%
    Dec 2024$8.63M-12.2%74.6%-78.3%-54.6%
    Dec 2023$9.83M+11.6%69.1%-72.3%-71.0%
    Dec 2022$8.81M-14.5%55.7%-100.2%-99.6%
    Dec 2021$10.30M+89.5%61.3%-71.6%-66.7%
    Dec 2020$5.44M-35.1%66.6%-137.1%-135.9%
    Dec 2019$8.37M-13.0%68.3%-47.8%-90.5%
    Dec 2018$9.62M-14.7%46.1%-83.1%-79.9%
    Dec 2017$11.28M+7.6%61.8%-46.4%-47.6%
    Dec 2016$10.48MN/A60.2%-62.1%-69.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$8.97M$8.63M$9.83M$8.81M$10.30M$5.44M$8.37M$9.62M$11.28M$10.48M
    Cost of revenue$2.57M$2.20M$3.03M$3.91M$3.99M$1.82M$2.66M$5.19M$4.31M$4.18M
    Gross profit$6.41M$6.43M$6.79M$4.90M$6.31M$3.62M$5.72M$4.43M$6.97M$6.31M
    Research and development$449.47K$858.77K$701.38K$1.15M$878.21K$307.85K$189.92K$245.64K$272.75K$1.27M
    Operating income-$5.70M-$6.76M-$7.11M-$8.83M-$7.38M-$7.45M-$4.00M-$8.00M-$5.23M-$6.51M
    Net income-$5.72M-$4.71M-$6.98M-$8.77M-$6.88M-$7.39M-$7.58M-$7.69M-$5.37M-$7.29M
    EBITDA-$5.51M-$4.64M-$6.96M-$8.68M-$7.23M-$7.36MN/A-$6.80M-$4.79M-$6.36M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$2.22M$2.84M$2.16M$2.06M$2.36M$2.32M$2.23M$2.01M$2.51M$1.85M$2.25M$2.26M
    Gross profit$1.61M$1.91M$1.56M$1.50M$1.64M$1.62M$1.65M$1.51M$1.84M$1.41M$1.68M$1.51M
    Operating income-$746.29K-$1.06M-$828.08K-$1.08M-$1.13M-$1.48M-$2.00M-$2.04M-$1.47M-$1.78M-$1.47M-$1.98M
    Net income-$747.54K-$1.06M-$839.85K-$1.09M-$1.15M-$1.48M-$1.99M-$2.04M-$1.46M$223.64K-$1.44M-$1.96M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $957.70K by $154.94K.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$7.81M$9.80M$11.37M$13.70M$19.81M$19.57M$6.56M$6.40M$15.63M$14.18M
    Current assets$7.48M$9.29M$10.79M$12.97M$18.93M$18.55M$6.08M$5.86M$12.02M$13.34M
    Cash and equivalents$1.11M$3.26M$2.98M$8.72M$14.76M$14.22M$1.52M$743.43K$2.64M$3.60M
    Total liabilities$4.80M$3.96M$3.36M$3.70M$3.59M$3.46M$4.93M$4.87M$8.13M$5.65M
    Short-term debt$157.70K$128.81K$113.69K$101.07K$89.55K$276.18K$0$1.66M$985.68KN/A
    Long-term debt$800.00K$0N/AN/AN/AN/AN/AN/A$0$0
    Shareholder equity$3.01M$5.83M$8.01M$10.23M$16.37M$16.20M$1.70M$1.54M$7.24M$8.50M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$6.94M$8.35M$7.96M$7.81M$8.49M$8.05M$9.09M$9.80M$11.17M$12.01M$11.35M$11.37M
    Total liabilities$3.29M$4.88M$5.68M$4.99M$5.94M$4.71M$4.63M$3.96M$3.95M$4.05M$3.89M$3.36M
    Cash and equivalents$1.32M$2.07M$1.19M$1.11M$1.35M$1.27M$2.25M$3.26M$4.78M$5.75M$4.01M$2.98M
    Shareholder equity$3.66M$3.47M$2.28M$2.81M$2.55M$3.34M$4.46M$5.83M$7.22M$7.95M$7.46M$8.01M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$2.92M-$2.92M-$5.33M-$6.03M-$4.03M-$6.98M-$1.78M-$1.63M-$1.23M-$5.40M
    Capital expenditures$15.12K$10.12K$4.88K$8.53K$15.19K$21.44K$9.92K$7.40K$6.01K$15.34K
    Free cash flow-$2.93M-$2.93M-$5.33M-$6.04M-$4.05M-$7.01M-$1.79M-$1.64M-$1.24M-$5.41M
    Investing cash flow-$15.12K$2.97M-$2.97M-$8.53K-$15.19K-$21.44K-$9.92K-$15.42K-$199.18K$8.21K
    Financing cash flow$786.34K$233.77K$2.56M-$8.54K$4.59M$19.71M$2.56M-$250.00K$463.34K$4.80M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$746.30K-$585.13K$86.84K-$226.13K$81.78K-$1.76M-$1.01M-$1.51M-$973.91K$783.65K-$1.22M-$1.25M
    Capital expenditures$1.66K$4.14K$1.63K$3.12K$6.23K$4.47K$1.30K$3.53K$6.60K$6.60K$0$3.69K
    Free cash flow-$747.96K-$589.27K$85.21K-$229.25K$75.54K-$1.77M-$1.01M-$1.52M-$980.51K$777.06K-$1.22M-$1.25M
    Last 12 quarters

    Frequently Asked Questions About MLSS

    What is Milestone Scientific's annual revenue?

    Milestone Scientific reported revenue of $8.97M for the fiscal year ended Dec 31, 2025.

    How fast is Milestone Scientific's revenue growing?

    Revenue was up 4.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.6%.

    Is Milestone Scientific profitable?

    No. Milestone Scientific reported net income of -$5.72M for the fiscal year ended Dec 31, 2025, with a net margin of -63.8%.

    How much free cash flow does MLSS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$2.92M minus capital expenditures of $15.12K produced free cash flow of -$2.93M.

    How much debt does Milestone Scientific have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $800.00K, short-term debt of $157.70K and cash and equivalents of $1.11M.